Skip to main content
. 2022 Feb 7;12:718776. doi: 10.3389/fmicb.2021.718776

TABLE 1.

Clinicopathological features of the patients included in this study.

Patients (n = 32)
DEMOGRAPHIC FEATURES
Gender
Male 27
Female 5
Age in years, mean (rank) 67 (48–85)
CLINICAL FEATURES
DM, N (%)
No 26 (81.25)
Yes 6 (18.75)
Hypertension, N (%)
No 20 (62.50)
Yes 12 (37.50)
COPD, N (%)
No 24 (75.00)
Yes 8 (25.00)
Dyslipidemia, N (%)
No 20 (62.50)
Yes 12 (37.50)
Cardiovascular disease, N (%)
No 25 (78.12)
Yes 7 (21.88)
Functional status according to ECOG scale, N (%)
0 2 (6.25)
1 12 (37.5)
2 5 (15.63)
3 1 (3.13)
Unknown 12 (37.5)
TUMORAL FEATURES
Histology, N (%)
Urothelial 22 (68.75)
Non-Urothelial 9 (28.13)
Unknown 1 (3.13)
Grade, N (%)
Low 3 (9.38)
High 29 (90.62)
Stage of tumor, N (%)
I 0 (0.00)
II 6 (18.75)
III 13 (40.63)
IV 13 (40.63)
pT, N (%)
1 1 (3.12)
2 9 (28.13)
3 13 (40.62)
4 9 (28.13)
Lymph node affectation (%)
No 17 (53.13)
Yes 11 (34.37)
Unknown 4 (12.5)
Metastasis, N (%)
No 27 (84.38)
Yes 4 (12.50)
Unknown 1 (3.13)
Lymphovascular invasion, N (%)
No 7 (21.88)
Yes 24 (75.00)
Unknown 1 (3.13)
Death, N (%)
No 18 (56.25)
Yes 13 (40.62)
Unknown 1 (3.13)